SNY Sanofi
- 48.350
- +0.070+0.14%
- 48.380
- +0.030+0.06%
Sanofi News
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SANOFI(15.80%)
3: Initial statement of beneficial ownership of securities-10% Owner Sanofi
11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
SC 13G: Statement of acquisition of beneficial ownership by individuals-Sanofi(8.0%)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dodge & Cox(4.9%)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.2%)
Sanofi | SC 13G: Statement of acquisition of beneficial ownership by individuals-SANOFI(7.4%)
Sanofi | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Sanofi | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dodge & Cox(5.3%)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.2%)
Sanofi | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Sanofi | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Sanofi | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Sanofi | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Analysis
Price Target
No Data
No Data
